Arzu Yazal Erdem

Dr. Arzu Yazal Erdem

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
AEArzu Yazal Erdem
Arzu Yazal Erdem
FYFatma Demir Yenigürbüz
Fatma Demir Yenigürbüz
EPEsra Pekpak
Esra Pekpak
BABurcu Akıncı
Burcu Akıncı
EAElif Aktekin
Elif Aktekin
NÖNamık Yaşar Özbek
Namık Yaşar Özbek

7 May 2014 in Pediatric Transplantation
Verified
Journal Article
Closed access
PDF file
FAFatih Azik
Fatih Azik
AEArzu Yazal Erdem
Arzu Yazal Erdem
BTBetül Tavil
Betül Tavil
CBCengiz Bayram
Cengiz Bayram
BTBahattin Tunç
Bahattin Tunç
DUDuygu Uçkan
Duygu Uçkan

30 November 2020 in The Journal of Infection in Developing Countries
Verified
Journal Article
Open access
PDF file
AGAhmet Alptuğ Güngör
Ahmet Alptuğ Güngör
TDTugba Bedir Demirdag
Tugba Bedir Demirdag
BDBedia Dinç
Bedia Dinç
EAEmine Azak
Emine Azak
AEArzu Yazal Erdem
Arzu Yazal Erdem
NSNeriman Sarı
Neriman Sarı
Infective endocarditis (IE) is an infection of the endocardium and/or heart valves that involves thrombus formation (vegetation). This condition might damage the endocardial tissue and/or valves. An indwelling central venous catheter is a major risk factor for bacteremia at-risked pediatric populations such as premature infants; children with cancer and/or connective tissue disorders. Herbaspirillum huttiense is a Gram-negative opportunistic bacillus that may cause bacteremia and pneumonia rarely in this fragile population. Herein we report the very first case of bacteremia and IE in a pediatric oncology patient caused by H. huttiense.

22 June 2023 in The Journal of Pediatric Academy
Verified
Journal Article
Open access
PDF file
AYAyça Koca Yozgat
Ayça Koca Yozgat
DÖDerya Özyörük
Derya Özyörük
SESuna Emir
Suna Emir
ADAhmet Demir
Ahmet Demir
AEArzu Yazal Erdem
Arzu Yazal Erdem
NÖNamık Yaşar Özbek
Namık Yaşar Özbek
Cancer care is progressively became as a significant worldwide challenge. Wars can cause destructions and delays in cancer diagnosis and treatment of displaced people. Cancer cure rates need to be improved in indefensible populations such as refugees. In this study, we purposed to highlight the clinical peculiarities and outcomes of refugee children with cancer in our hospital. Our purpose was to present our findings and contribute to improve the health care for these children. Seventy one refugee pediatric patients admitted to the oncology and hematology units of our hospital between April 2011 and January 2019 were included in this study. The demographic characteristics of the patients at the initial diagnosis, their countries of origin, living conditions, histopathological diagnoses, treatments, relapse, and mortality data were analyzed retrospectively from the patient files. The median age of patients was 6.5±4.5 years, and the male-to-female ratio was 39/32. While 44 patients (61.9%) presented with complaints and had primary diagnoses in our hospital, the remaining 27 patients (38.1%) were diagnosed in their country and applied to our hospital for treatment. Our mean follow-up period was 18.2±18.8 months (1-90 months). As a result, 44 patients (62%) were alive and 22 (31%) were dead. The survival rate without relapse in the second year was 83.6%. Two and fiveyear survival rates were 77.5% vs. 58.1% respectively. Compared to Turkish children, lower survival rates were found in refugee children. In addition to cancer-specific factors such as tumor type and stage, some problems such as shelter, communication, adherence to treatment, and difficulties supplying medicine may be responsible for lower survival rates in refugee children. Further studies are needed to improve the survival rates of patients.

20 March 2014 in Pediatric Transplantation
Verified
Journal Article
Closed access
PDF file
AEArzu Yazal Erdem
Arzu Yazal Erdem
FAFatih Azık
Fatih Azık
BTBetül Tavil
Betül Tavil
STSERAP TEBER
SERAP TEBER
BTBahattin Tunç
Bahattin Tunç
DUDuygu Uçkan
Duygu Uçkan

1 August 2019 in Transfusion and Apheresis Science
Verified
Journal Article
Closed access
AEArzu Yazal Erdem
Arzu Yazal Erdem
ÖBÖzlem Arman Bilir
Özlem Arman Bilir
MIMelek Işık
Melek Işık
DKDilek Kaçar
Dilek Kaçar
NÖNamık Yaşar Özbek
Namık Yaşar Özbek
HYHüsniye Neşe Yaralı
Hüsniye Neşe Yaralı